• About
  • Advertise
  • Careers
  • Contact Us
Wednesday, June 25, 2025
  • Login
No Result
View All Result
NEWSLETTER
Tech | Business | Economy
  • News
  • Tech
    • DisruptiveTECH
    • ConsumerTech
    • How To
    • TechTAINMENT
  • Business
    • Telecoms
    • Mobility
    • Environment
    • Travel
    • StartUPs
      • Chidiverse
    • TE Insights
    • Security
  • Partners
  • Economy
    • Finance
    • Fintech
    • Digital Assets
    • Personal Finance
    • Insurance
  • Features
    • IndustryINFLUENCERS
    • Guest Writer
    • EventDIARY
    • Editorial
    • Appointment
  • TECHECONOMY TV
  • Apply
  • TBS
  • BusinesSENSE For SMEs
  • Chidiverse
  • News
  • Tech
    • DisruptiveTECH
    • ConsumerTech
    • How To
    • TechTAINMENT
  • Business
    • Telecoms
    • Mobility
    • Environment
    • Travel
    • StartUPs
      • Chidiverse
    • TE Insights
    • Security
  • Partners
  • Economy
    • Finance
    • Fintech
    • Digital Assets
    • Personal Finance
    • Insurance
  • Features
    • IndustryINFLUENCERS
    • Guest Writer
    • EventDIARY
    • Editorial
    • Appointment
  • TECHECONOMY TV
  • Apply
  • TBS
  • BusinesSENSE For SMEs
  • Chidiverse
No Result
View All Result
Tech | Business | Economy
No Result
View All Result
Home News

BGI Genomics Launches first Cervical Cancer Screening Program in Africa

Thousands of Rwandan Women will Benefit from BGI Genomics' Cervical Cancer Tests

by Staff Writer
May 15, 2024
in News
0
BGI Genomics in Rwanda
BGI Genomics in Rwanda during a programme

BGI Genomics in Rwanda during a programme

UBA
Advertisements

BGI Genomics have recently launched their first cervical cancer screening program in Africa with Rwanda being the first beneficiary.

The program that was initiated in Ngoma District in the Eastern Province of Rwanda will provide 20,000 Human papillomavirus (HPV) DNA tests for local women, aiming to enhance cervical cancer screening and prevention efforts and improve local precision medical testing capabilities.

The launching event was attended by Wang Xuekun, Chinese Ambassador to Rwanda; Mr. Pudence Rubingisa, Governor of Eastern Province; Nathalie Niyonagira, the Mayor of Ngoma District, Rwanda; Dr. Albert Tuyishime, Head of Department, (HDPC) HIV/AIDS Diseases Prevention and Control, RBC; Dr. Theoneste Maniragaba, Director of the Cancer Diseases Unit at the RBC; Dr. Du Yutao, Chief Operating Officer of BGI Genomics; and Gao Zhiqiang, Commercial Counsellor of the Chinese Embassy in Rwanda, among others.

Wang Xuekun, Chinese Ambassador to Rwanda
Advertisements
MTN ADS
Wang Xuekun, Chinese Ambassador to Rwanda

Wang Xuekun, Chinese Ambassador to Rwanda, stated: “BGI Genomics is a leading enterprise in the genomic industry, both in China and globally. The company has significantly contributed to promoting the friendship between China and Rwanda and advancing Rwanda’s medical and health industry.”

Mr. Pudence Rubingisa, Governor of Eastern Province
Pudence Rubingisa, Governor of Eastern Province

Mr. Pudence Rubingisa, Governor of Eastern Province, commented, “We deeply appreciate our collaboration with BGI Genomics and other partners. As we initiate this project, we are dedicated to leveraging all available resources, including our local health workers and agencies, to facilitate effective screening, awareness, and educational efforts. This initiative is pivotal for enhancing the well-being of our community.”

Dr. Albert Tuyishime, Head of the HIVAIDS Disease Prevention and Control Department at RBC
Dr. Albert Tuyishime, Head of the HIVAIDS Disease Prevention and Control Department at RBC

Dr. Albert Tuyishime, Head of the HIV/AIDS Disease Prevention and Control Department at RBC, remarked,

“Cervical cancer is a major global challenge, particularly in developing countries with limited treatment options. Rwanda aims to lead the way in achieving the global cervical cancer elimination goals. We value our collaboration with BGI Genomics, which has enhanced screening services in the Ngoma district, and look forward to extending these services across the country.”

As Rwanda’s public health implementation agency, the RBC is committed to enhancing the local public health through scientific research, diagnostic services, and innovative healthcare interventions.

For this initiative, BGI Genomics provides a comprehensive solution comprising laboratory equipment and technology transfer, while all project samples and testing data are handled by Rwanda’s personnel and stored locally under local laws and regulations.

The company will also assist in further upgrading the local closed-loop management system from cervical cancer screening to positive intervention, significantly enhancing Rwanda’s healthcare infrastructure.

The Chinese medical team assisting Rwanda provides support for the implementation of the cervical cancer screening project, and the team’s leader Zhang Heping also attended the launching ceremony.

Cervical cancer ranks as the second most prevalent cancer among women in Rwanda. According to data from the Rwanda Health Management Information System (HMIS), only 24% of eligible women in Rwanda have undergone cervical cancer screening in the past five years.

According to the WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, HPV DNA testing, with an accuracy rate of up to 95%, are the first-choice screening method for cervical cancer screening. A self-sampling model is recommended, whereby women collect their test samples, followed by centralized testing.

Dr. Du Yutao, Chief Operating Officer of BGI Genomics

“In China, HPV DNA testing technology has been applied in many large-scale public health service programs and achieved remarkable results. We hope that cervical cancer screening can leverage BGI Genomics technology and self-sampling model in countries worldwide and help accelerate the goal of eliminating cervical cancer worldwide,” said Dr. Du Yutao, Chief Operating Officer of BGI Genomics.

BGI Genomics self-developed HPV DNA testing products are suitable for large-scale population screening and precise HPV genotyping.

A single test can screen for the 14 high-risk HPV types highly correlated with the occurrence of cervical cancer as per WHO guidelines and is validated by large-scale clinical data to be suitable for self-sampling.

Local personnel provide training to eligible women on the proper techniques for self-sampling.
Local personnel provide training to eligible women on the proper techniques for self-sampling.

A self-sampling model requires only a few medical staff to facilitate the rapid collection of many samples, which significantly enhances accessibility and effectively enables screening to cover areas with limited medical resources.

Notably, this approach offers considerable advantages in remote regions of developing countries where cold chain logistics are inadequate, as it minimizes the necessity for advanced transportation and storage infrastructure. The ease of use, convenience, and privacy will further enhance screening coverage.

In the future, BGI Genomics plans to deliver advanced genetic testing technologies for reproductive health, tumor screening, and the prevention and control of infectious diseases in Rwanda.

This will promote the overall capacity and efficacy of precision medicine and help upgrade the local medical and healthcare systems.

[Featured Image Credit]

Loading

Author

  • Staff Writer
    Staff Writer

    View all posts
0Shares
Tags: BGI GenomicsRwanda
Staff Writer

Staff Writer

Next Post
Tosin Eniolorunda, Group CEO of Moniepoint Inc

Moniepoint Inc Ranked as Africa’s Fastest Growing Financial Institution by FT Ranking - Two Years Running

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

I agree to the Terms & Conditions and Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Recommended

Illicit Funds for Recapitalization | Naira

Naira Continues to Fall in Official Market, Closes at N1,610/$1

2 months ago
FSCA and South African Financial sector

FSCA: South African Financial Institutions under Pressure

7 months ago

Popular News

    Connect with us

    • About
    • Advertise
    • Careers
    • Contact Us

    © 2025 TECHECONOMY.

    No Result
    View All Result
    • News
    • Tech
      • DisruptiveTECH
      • ConsumerTech
      • How To
      • TechTAINMENT
    • Business
      • Telecoms
      • Mobility
      • Environment
      • Travel
      • StartUPs
        • Chidiverse
      • TE Insights
      • Security
    • Partners
    • Economy
      • Finance
      • Fintech
      • Digital Assets
      • Personal Finance
      • Insurance
    • Features
      • IndustryINFLUENCERS
      • Guest Writer
      • EventDIARY
      • Editorial
      • Appointment
    • TECHECONOMY TV
    • Apply
    • TBS
    • BusinesSENSE For SMEs

    © 2025 TECHECONOMY.

    Welcome Back!

    Login to your account below

    Forgotten Password?

    Retrieve your password

    Please enter your username or email address to reset your password.

    Log In
    Translate »
    This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.